• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

Stem = downsize





















Youre an idiot. Its a marketing initiative which we need to jumpstart.

STEM is a marketing / performance audit company. It's called Google to research and you don't pay for a "jump start" in the fourth quarter, when you're behind budget, in "smarter ways" for a marketing initiative. I like your optimism though...
 
























Part of the Stem purpose is to get a feel for need in the field. Some territories have woefully low potential due to Managed care access. These territories will become Hybrid territories, eliminating 1 position per consolidation. "Some" territories will go hybrid next year.
 












Why would we go back to hybrids after just getting rid of them and making districts and regions specialty-specific again?! That's crazy.

Non-Hybrid only works when you're doing volume and/or have density. Low $ sales drugs cannot support a sales force. Gotta achieve a certain dollar sales per rep.

IT WILL HAPPEN.